| Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine LR Baden, HM El Sahly, B Essink, K Kotloff, S Frey, R Novak, D Diemert, ... New England journal of medicine 384 (5), 403-416, 2021 | 10985 | 2021 |
| An mRNA vaccine against SARS-CoV-2—preliminary report LA Jackson, EJ Anderson, NG Rouphael, PC Roberts, M Makhene, ... New England journal of medicine 383 (20), 1920-1931, 2020 | 3681 | 2020 |
| Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults EJ Anderson, NG Rouphael, AT Widge, LA Jackson, PC Roberts, ... New England Journal of Medicine 383 (25), 2427-2438, 2020 | 1702 | 2020 |
| Durability of responses after SARS-CoV-2 mRNA-1273 vaccination AT Widge, NG Rouphael, LA Jackson, EJ Anderson, PC Roberts, ... New England Journal of Medicine 384 (1), 80-82, 2021 | 849 | 2021 |
| Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19 N Doria-Rose, MS Suthar, M Makowski, S O’Connell, AB McDermott, ... New England Journal of Medicine 384 (23), 2259-2261, 2021 | 719 | 2021 |
| Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase HM El Sahly, LR Baden, B Essink, S Doblecki-Lewis, JM Martin, ... New England Journal of Medicine 385 (19), 1774-1785, 2021 | 581 | 2021 |
| Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ... Science 373 (6561), 1372-1377, 2021 | 564 | 2021 |
| Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 years—United States, July–December 2021 LD Zambrano MMWR. Morbidity and mortality weekly report 71, 2022 | 315 | 2022 |
| BNT162b2 protection against the omicron variant in children and adolescents AM Price, SM Olson, MM Newhams, NB Halasa, JA Boom, LC Sahni, ... New England Journal of Medicine 386 (20), 1899-1909, 2022 | 265 | 2022 |
| Effectiveness of BNT162b2 vaccine against critical Covid-19 in adolescents SM Olson, MM Newhams, NB Halasa, AM Price, JA Boom, LC Sahni, ... New England Journal of Medicine 386 (8), 713-723, 2022 | 209 | 2022 |
| Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19–associated hospitalization in infants aged 6 months—17 states, July 2021 … NB Halasa MMWR. Morbidity and mortality weekly report 71, 2022 | 205 | 2022 |
| Maternal vaccination and risk of hospitalization for Covid-19 among infants NB Halasa, SM Olson, MA Staat, MM Newhams, AM Price, PS Pannaraj, ... New England Journal of Medicine 387 (2), 109-119, 2022 | 192 | 2022 |
| Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant KE Lyke, RL Atmar, CD Islas, CM Posavad, D Szydlo, RP Chourdhury, ... Cell Reports Medicine 3 (7), 2022 | 155 | 2022 |
| Effectiveness of Pfizer-BioNTech mRNA vaccination against COVID-19 hospitalization among persons aged 12–18 years—United States, June–September 2021 SM Olson MMWR. Morbidity and mortality weekly report 70, 2021 | 128 | 2021 |
| Reported cases of multisystem inflammatory syndrome in children aged 12–20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a … AR Yousaf, MM Cortese, AW Taylor, KR Broder, ME Oster, JM Wong, ... The Lancet Child & Adolescent Health 6 (5), 303-312, 2022 | 127 | 2022 |
| COVID-19 vaccine development: a pediatric perspective S Kamidani, CA Rostad, EJ Anderson Current opinion in pediatrics 33 (1), 144-151, 2021 | 123 | 2021 |
| Warp speed for coronavirus disease 2019 (COVID-19) vaccines: why are children stuck in neutral? EJ Anderson, JD Campbell, CB Creech, R Frenck, S Kamidani, FM Munoz, ... Clinical Infectious Diseases 73 (2), 336-340, 2021 | 109 | 2021 |
| US Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines D Gubernot, A Jazwa, M Niu, J Baumblatt, J Gee, P Moro, J Duffy, ... Vaccine 39 (28), 3666-3677, 2021 | 79 | 2021 |
| Epidemiology, clinical characteristics, and outcomes of influenza-associated hospitalizations in US children over 9 seasons following the 2009 H1N1 pandemic S Kamidani, S Garg, MA Rolfes, AP Campbell, CN Cummings, JC Haston, ... Clinical Infectious Diseases 75 (11), 1930-1939, 2022 | 29 | 2022 |
| BNT162b2 mRNA vaccination against COVID-19 is associated with decreased likelihood of multisystem inflammatory syndrome in US children ages 5–18 years LD Zambrano, MM Newhams, SM Olson, NB Halasa, AM Price, AO Orzel, ... Clinical Infectious Diseases: An Official Publication of the Infectious …, 2022 | 29 | 2022 |
